Click Here for 5% Off Your First Aladdin Purchase!

Vecuronium Bromide - ≥99%, high purity , CAS No.50700-72-6

  • ≥99%
Item Number
V129458
Grouped product items
SKUSizeAvailabilityPrice Qty
V129458-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$48.90
V129458-100mg
100mg
In stock
$162.90
V129458-250mg
250mg
In stock
$366.90
V129458-1g
1g
In stock
$1,320.90
V129458-5g
5g
In stock
$5,941.90
V129458-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$26,736.90

Competitive nicotinic acetylcholine receptor (nAChR) antagonist

Basic Description

SynonymsVECURONIUM BROMIDE|50700-72-6|Norcuron|ORG NC 45|Vecuronii bromidum|Bromuro de vecuronio|Bromure de vecuronium|ORG-NC 45|Vecuronium (bromide)|UNII-7E4PHP5N1D|EINECS 256-723-9|7E4PHP5N1D|CHEBI:9940|Vecuronii bromidum [INN-Latin]|DTXSID1023736|Bromure de ve
Specifications & Purity≥99%
Biochemical and Physiological MechanismsVecuronium (Norcuron) is a muscle relaxant in the category of non-depolarizing blocking agents. Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during sur
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Vecuronium Bromide is a nonpolarizing neuromuscular relaxant.
A nonpolarizing neuromuscular relaxant

Names and Identifiers

IUPAC Name [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide
INCHI InChI=1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1
InChi Key VEPSYABRBFXYIB-PWXDFCLTSA-M
Canonical SMILES CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
Isomeric SMILES CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
WGK Germany 3
RTECS TN4875000
PubChem CID 39764
Molecular Weight 637.73
Beilstein 4837308
Reaxy-Rn 4106207

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

7 results found

Lot NumberCertificate TypeDateItem
F2220047Certificate of AnalysisApr 02, 2024 V129458
F2220046Certificate of AnalysisApr 02, 2024 V129458
C2201180Certificate of AnalysisDec 22, 2023 V129458
C2201193Certificate of AnalysisDec 22, 2023 V129458
C2201195Certificate of AnalysisDec 22, 2023 V129458
C2202080Certificate of AnalysisDec 22, 2023 V129458
E1525112Certificate of AnalysisJan 16, 2023 V129458

Chemical and Physical Properties

SolubilitySoluble in water, DMSO (128 mg/ml at 25 °C), and ethanol (128 mg/ml at 25 °C).
SensitivityHeat Sensitive
Specific Rotation[α]32° (C=1,0.05mol/L HCl)
Melt Point(°C)235 °C(dec.)

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS07
Signal Danger
Hazard Statements

H302:Harmful if swallowed

H312:Harmful in contact with skin

H330:Fatal if inhaled

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P284:[In case of inadequate ventilation] Wear respiratory protection.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P320:Specific treatment is urgent (see ... on this label).

P301+P317:IF SWALLOWED: Get medical help.

P317:Get emergency medical help.

P316:Get emergency medical help immediately.

WGK Germany 3
RTECS TN4875000
Reaxy-Rn 4106207
Merck Index 9941

Related Documents

References

1. Fan G et al..  (2019)  Decreased levels of H3K9ac and H3K27ac in the promotor region of ovarian P450 aromatase mediated low estradiol synthesis in female offspring rats induced by prenatal nicotine exposure as well as in human granulosa cells after nicotine treatment..  Food Chem Toxicol,  128  (256-266).  [PMID:30959089]
2. Pei Y et al..  (2019)  Excitotoxicity and compensatory upregulation of GAD67 in fetal rat hippocampus caused by prenatal nicotine exposure are associated with inhibition of the BDNF pathway..  Food Chem Toxicol,  123  (314-325).  [PMID:30389584]
3. Zhou J et al..  (2018)  nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11ß-HSD2..  Toxicol Appl Pharmacol,  344  (1-12).  [PMID:29486207]
4. Zhang G et al..  (2018)  Placental mechanism of prenatal nicotine exposure-reduced blood cholesterol levels in female fetal rats..  Toxicol Lett,  296  (31-38).  [PMID:30036686]

Solution Calculators